ESSA Pharma Inc
EPIX
|
|
|
|
Trading Volume | 7,348 |
|
10.65 - 2.65 |
Market Cap Full | $ 242.3M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 3.6% | 29.4% | 17.9% | -55.4% |
Q2 | - | -38% | -9.1% | -50.3% |
Q3 | - | 5.6% | 14.4% | -42.2% |
Q4 | - | 0.6% | 124.5% | 38.5% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
3.6 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
25.6 | 14.6 | -10.1 | -26.1 | 7.3 | -22.6 | -0.8 | 5.6 | - | - | - | 0.3 |
2023 | |||||||||||
12.7 | 18.5 | -11.7 | -7.4 | 9.1 | -10 | 11.9 | -0.7 | 3 | 50.5 | 14.4 | 24.1 |
2022 | |||||||||||
-34.4 | -12.2 | -22.4 | -10.6 | -10.9 | -37.6 | -12.4 | -6.5 | -29.5 | 97.8 | 2.5 | -31.7 |
2021 | |||||||||||
49.8 | 49.8 | 11.5 | 0.1 | 4.6 | -9.7 | -21.7 | -57.6 | -15.6 | 13.8 | 43.6 | 8.7 |
2020 | |||||||||||
5.5 | -14 | -16.7 | 8.9 | 19.9 | 18.8 | 12.7 | -0.4 | -0.9 | -11.6 | 14.8 | 72.4 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.2 | -0.3 | -0.4 | -0.5 |
Q2 | -0.2 | -0.2 | -0.2 | -0.2 |
Q3 | -0.1 | -0.1 | -0.2 | -0.1 |
Q4 | 0 | -0.2 | -0.2 | -0.2 |
A | -0.45 | -0.8 | -1 | -1 |